Early Stage Drug Treatment That Normalizes Proinflammatory Cytokine Production Attenuates Synaptic Dysfunction in a Mouse Model That Exhibits Age-Dependent Progression of Alzheimer's Disease-Related Pathology
Adam D. Bachstetter(University of Kentucky), Linda J. Van Eldik(University of Kentucky)
Cited by 121
Related Papers
Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ)
|Journal of Neuroinflammation|2011|283
The p38α MAPK Regulates Microglial Responsiveness to Diffuse Traumatic Brain Injury
|Journal of Neuroscience|2013|127
Target Engagement Analysis and Link to Pharmacodynamic Endpoint for a Novel Class of CNS-penetrant and Efficacious p38α MAPK Inhibitors
|Journal of Neuroimmune Pharmacology|2014|13
A blunted TH17 cytokine signature in women with mild cognitive impairment: insights from inflammatory profiling of a community-based cohort of older adults
|Brain Communications|2023|8
Terminally differentiated effector memory T cells associate with cognitive and AD-related biomarkers in an aging-based community cohort
|bioRxiv (Cold Spring Harbor Laboratory)|2023|4